My Peptide Partners retatrutide order: shipping, COAs and safety

I wanted to write down exactly how my Peptide Partners order went, then look beyond the package itself. That meant checking the company's certificates of analysis, Finnrick's testing records, and the public information about the people behind the business.

This is my personal account. It is not medical advice, a dosing guide, or a recommendation to ingest or inject a research chemical.

What I ordered

I ordered the Peptide Partners listing sold as GLP-3 Retatrutide (24 mg vials), along with its Reconstitution Solution (BAC, 10 mL vials; 20 mL total). The package arrived through FedEx in four days. My delivery did not require a signature. I was able to pay by credit card during checkout.

Nothing looked wrong when I opened the package. The reconstitution solution was clear, with no visible cloudiness. I was happy with the condition of the order.

That only tells me how the package and liquid looked. A visual check cannot confirm sterility, identity, concentration, purity, or whether something is suitable for human use.

My personal result

I lost 32 pounds over four months while using what I believed was retatrutide at 2 mg per week. I did not notice an immediate product issue, and I was happy with the purchase itself.

This is one unverified personal experience. It does not prove that the product caused my weight change, contained retatrutide, had an accurate dose, or was safe. I am including the amount because it was part of my experience, not because anyone else should copy it. Lilly says retatrutide is legally available only through its clinical trials, where researchers control the product identity, dosing, monitoring, and reporting of adverse events.

Checking the COAs

Peptide Partners has an Independent Certifications page. When I checked it, the table listed Retatrutide batch RTT2613 with a test dated July 2, 2026. It reported 99.77% purity and linked to a laboratory file. Anyone reviewing a COA should compare its batch number with the number printed on the vial.

A COA posted by a vendor is useful paperwork, but it cannot independently prove what is inside every vial that ships. It also cannot turn an investigational compound into an approved medicine. Identity, fill quantity, purity, sterility, endotoxin, and heavy metals are separate questions. A single purity result does not answer all of them.

What I found on Finnrick

I also checked Finnrick's Peptide Partners vendor page. The results are more useful than a simple collection of positive reviews because they are mixed. Finnrick gives Peptide Partners retatrutide a 91% rating based on 23 tests. Across the vendor's catalog, it reports 52 passes among 76 classifiable tests and places the vendor 231st out of 283. Retatrutide is one of the stronger records on the page, while some other products have weaker results.

The public page also shows test dates, pass or fail results, sample volume, and information about the methods used. Finnrick members can open the original laboratory PDFs. I think it makes sense to read those records alongside the vendor's own COAs. Neither source cancels the FDA's warning.

Who is behind Peptide Partners?

Bloomberg identifies Zak David as the managing partner of Pirsek Technologies, the company that operates Peptide Partners. He talks publicly about the peptide market and posts on X as @ZakDavid.

On November 7, 2025, Zak appeared on Boys Club episode 216, "Chinese Peptides" Explainer with Zak David of Peptide Partners. The conversation covers FDA status, testing methods, screening for endotoxin and heavy metals, sourcing, and manufacturing.

He also appeared on Bloomberg Odd Lots on December 19, 2025, in an episode called The Booming Business of Chinese Peptides. Bloomberg describes Peptide Partners as a peptide supplier operated by Pirsek Technologies.

The FDA warning matters

The Peptide Partners product page repeatedly says "for research use only," "not suitable for human consumption," and "not for human or veterinary use." Those words should be taken literally.

The FDA's GLP-1 safety notice says retatrutide is not part of an FDA approved drug, cannot lawfully be used in compounding, and has not been found safe and effective for any condition. The agency specifically warns about products sold to consumers as retatrutide while carrying labels such as "for research purposes" or "not for human consumption."

Eli Lilly says the same thing plainly: retatrutide remains investigational and should not be taken outside a Lilly sponsored clinical trial. Products from unknown or unregulated sources may have the wrong amount, contaminants, impurities, a different ingredient, or no retatrutide at all.

How I see the purchase now

The ordering process itself was easy. I paid by credit card, FedEx delivered the package in four days without requiring a signature, and the BAC water looked clear. Peptide Partners publishes batch documents, Finnrick adds independent testing history, and Zak David has discussed the company on Boys Club and Bloomberg.

I can be pleased with the delivery and still be honest about what those facts do not establish. They do not make a research chemical an approved medicine, and they do not verify that it is safe for human use. Anyone looking for obesity treatment or care for another condition should discuss FDA approved options with a licensed clinician instead of using a product labeled for laboratory research.